- Article
- Source: Campus Sanofi
- 5 Sep 2025
VESTIGE Trial Results: Dupilumab in Type 2 Asthma
This video presents results from the Phase 4 VESTIGE trial, demonstrating how dupilumab improves airway structure and function in severe type 2 asthma. Using breakthrough Functional Respiratory Imaging technology, the study reveals structural improvements that conventional lung function tests may not detect.
MAT-BH-2500297